News Focus
News Focus
icon url

Couch

07/18/12 7:40 AM

#21729 RE: richme #21726

I agree it isn't so much of what specific abuse resistant opioid is released but that Elite gets a couple of them to market. Saying that I do think given Elite's pipeline the likely candidate is Hydromorphone first.

However, to say that the PPS predictions did not come true misses the point that the company almost went bankrupt and the PPS went as low as the .03's and we are sitting between .10~.12 currently. In addition, I see few people continuing to predict $1 or $5. I see people talking about their excitement that Elite will be producing a whole line of abuse resistant opioids. And, yes, I do believe Jerry Treppel when he says that is what the company is heading towards including the Nasdaq.
icon url

tangerine

07/18/12 10:02 AM

#21744 RE: richme #21726

You still don't get it or well maybe you do LOL LOL
Announcements of BE and 505B2 trials for multiple abuse resistant products for a line of abuse resistant products will be huge.

The other products will get launched in time, some at any point. The company is changing its focus towards abuse resistant opioid line now.

Why? Because they have the products and development deals to be and expect to be profitable!

Everyone wants PH3 to start right? Well it basically is about too!!! That is what hasn't sunk in yet and really only folks that listen to the CC know that. Its not 24 hour oxycodone but it is opioids which carry large revenue numbers and Elite has a good chance to have the first products in that space too.

They expect to get to where they should be and where the company always wanted to be!!! And that is an almost direct quote.

So good luck in your accumulation....